期刊文献+

葛根素对子宫内膜RL95-2细胞P450芳香化酶表达的调控作用(英文) 被引量:2

Regulation of aromatase P450 expression by puerarin in endometrial cell line RL95-2
下载PDF
导出
摘要 目的:探讨葛根素对子宫内膜RL95-2细胞P450芳香化酶(aromatase P450,P450arom)表达的影响及其对RL95-2细胞P450arom基因表达的调控作用。方法:将梯度稀释的葛根素在不同时间点加入RL95-2细胞中,分别采用实时聚合酶链反应(real-time polymerase chain reaction,RT-PCR)检测药物对RL95-2细胞P450arom mRNA表达水平的影响。以人类基因组DNA为模板扩增人P450arom组织特异性启动子2(PⅡ)转录起始位点上游序列。PCR产物定向克隆到报告基因载体pGL3-Basic中,构建人P450aromPⅡ系列报告基因质粒,并经限制性内切酶消化鉴定和基因测序证实。瞬时转染系列重组质粒至RL95-2细胞,加入葛根素刺激,分析相关转录因子,利用RT-PCR及Western blotting方法检测相关转录因子在葛根素作用下mRNA及蛋白表达的变化。结果:与溶剂对照组比较,低浓度葛根素会抑制P450arom mRNA表达(P<0.01),抑制作用在6、12 h较显著(P<0.01)。经酶切鉴定、基因测序、转录因子分析及启动子活性测定,成功构建了人P450aromPⅡ系列重组质粒(-1 017,-763,-543,-234^+8 bp)。瞬时转染系列质粒至细胞中,于12 h后加入葛根素(10-7mol/L)刺激,又12 h后检测荧光蛋白水平。结果表明,-763^-543 bp间的活性被抑制(P<0.05),通过转录因子分析找到了-410/-401 bp的AP-1(c-jun/c-fos)。利用RT-PCR、Western blotting及荧光素酶活性检测发现葛根素(10-7mol/L)对AP-1(c-jun/c-fos)的抑制作用平行于对P450arom的作用。结论:低浓度葛根素对子宫内膜RL95-2细胞P450芳香化酶基因表达的抑制作用很可能是受上游调控转录因子AP-1(c-jun/c-fos)的影响。 Objective: To study the effects of puerarin on the aromatase P450(P450arom) mRNA expression and the effects of low-dose puerarin on transcription factors of the P450arom gene(PⅡ) 5'-flanking region.Methods: The effects of puerarin on the P450arom mRNA expression were determined by real-time polymerase chain reaction(RT-PCR).The 5'-flanking region was amplified by PCR using human genomic cDNA as a template.By means of the restriction sites and sequence confirmation,the PCR product was cloned into reporter vector.Series of sequential deletion reporter constructs were transiently transfected into RL95-2 cells which were treated with or without puerarin.Luciferase activity was measured by Dual-Luciferase Reporter Assay System and Luminoskan Ascent luminometer.Furthermore,by using web-based search program,the most possible cis-acting elements and transcription factors were evaluated.Results: The data demonstrated that low-dose puerarin treatment could decrease P450arom expression at mRNA level compared to dimethyl sulphoxide(DMSO) treatment(P〈0.01),and puerarin(10^-7 mol/L) had a time-course effect on P450arom mRNA expression,which reached the bottom at 12 h(P〈0.01).Cells transfected with the-763/+8 bp constructs showed decrease in relative luciferase activity after puerarin(10^-7 mol/L) treatment compared to DMSO treatment(P〈0.05),indicating an essential regulatory site between-763 bp and-543 bp responsible for the transcription suppression by puerarin.Furthermore,the most possible transcription factors,which turned out to be AP-1(c-jun/c-fos) at-410/-401 bp were also evaluated.The activity of exogenous AP-1 was reduced after 12 hours of puerarin treatment(P〈0.05).The inhibition of c-jun mRNA also showed a time-course effect,which bottomed out at 12 h in parallel with that of P450arom(P〈0.01).The protein level of c-jun was also down-regulated by puerarin(10^-7mol/L) treatment at 12 h.Conclusion: The suppression of P450arom expression and activity may be associated with the down-regulation of transcription factor AP-1/c-jun.This partially explains the mechanisms whereby puerarin treats endometriosis.
出处 《中西医结合学报》 CAS 2008年第10期1017-1023,共7页 Journal of Chinese Integrative Medicine
基金 国家自然科学基金资助项目(No.30672742No.30371838)
关键词 葛根素 芳香化酶P450 子宫内膜异位症 puerarin, aromatase P450, endometriosis
  • 相关文献

二级参考文献11

  • 1Shankland S J, Scholey JW. Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney Int1995; 47: 782-8.
  • 2Murphy M, McGinty A, Godson C. Protein kinase C: potential targets for intervention in diabetic nephropathy. Curr Opin Nephrol Hypertens 1998; 7: 563-70.
  • 3Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-66.
  • 4Pariat M, Salvat C, Bebien M, Brockly F, Altieri E, Carillo S, et al. The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers. Biochem J 2000; 345: 129-38.
  • 5Gao YJ, Yue ZJ, Yan LJ, Nan CH, Li DM. Effects of high glucose condition on expression of extracellular matrix of glomerular mesangial cells in rats. Sect Clin Biochem & Lab Med Foreign Med Sci 2004; 25: 99-101.
  • 6Kikkawa R, Koya D, Haneda M. Progression of diabetic nephropathy. Am J Kidney Dis 2003; 41: S19-21.
  • 7Haneda M, Koya D, Kikkawa R. Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway. Am J Kidney Dis 2001;38: 178-81.
  • 8Zhang L, Zhang L, Zhao GS. The regulation of AP-1 on mitosin activating protein kinase signaling pathway. Pathophysiol Clin Med 2002; 20: 32-5.
  • 9Mao CP, Gu ZL. Researches of puerarin on pharmacological effect and clinical application. Chin J Hemorh 2004; 14: 138-42.
  • 10Mei CL, Zhang LM, Chen L. Establish and identify rat mesangial cells. J Nephro Dial Transplant 1996; 5: 90-2.

共引文献18

同被引文献25

  • 1石书芳,俞超芹,刘玉环,崔英,惠宁.人在位和异位子宫内膜腺上皮细胞和间质细胞的原代培养[J].第二军医大学学报,2004,25(11):1228-1231. 被引量:8
  • 2章瑜,陈跃进.黄樟油的毒性研究[J].苏州医学院学报,1995,15(2):241-242. 被引量:21
  • 3林娜,胡建平.中药胚胎毒性的研究现状和展望[J].中国中药杂志,2005,30(17):1317-1320. 被引量:15
  • 4俞超芹,石书芳,刘玉环,王瑞霞,宋艳华,俞瑾.人子宫内膜异位症在位和异位内膜细胞原代培养及形态学观察[J].中西医结合学报,2006,4(2):189-193. 被引量:19
  • 5Utsunomiya H, Cheng YH, I.in Z, Reierstad S, Yin P, Attar E, Xue Q, Imir G, Thung S, Trukhacheva E, Suzuki T, Sasano H, Kim J J, Yaegashi N, Bulun SE. Upstream stirnulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. Mol Endocrinol. 2008; 22(4):904-914.
  • 6Xue Q, Lin Z, Yin P, Milad MP, Cheng YH, Confino E, Reierstad S, Bulun SE. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5CpG island in endometriosis. J Clin Endocrinol Metab. 2007 ; 92(8):3261-3267.
  • 7Le Bail JC, Champavier Y, Chulia AJ, Habrioux G. Effects of phytoestrogens on aromatase, 3beta and 17beta hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci. 2000; 66 (14): 1281-1291.
  • 8Whitehead SA, Lacey M. Phytoestrogens inhibit aromatase but not 17β-hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa luteal cells: evidence for FSH induction of 1713 HSD. Human Reproduction. 2003; 18(3): 487-94.
  • 9Peeters LLH, Vigne JL, Tee MK, Zhao D, Wsite LL, Taylor RN. PPARgamma represses VEGF expression in human endometrial cells: Implications for uterine angiogenesis. Angiogenesis. 2006; 8(4): 373-379.
  • 10Koninckx PR, Barlow D, Kennedy S. Implantation infiltration : the Sampson versus the endometriotic disease theory. Gynecol Obstet Invest.1999; 47 Supp 1: 3-9.

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部